Showing results (21-30 of 125) with videos related to
Sort By:
Pageof 13
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 1, 1978
[Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma]K Korth, W Wetterauer, U Wetterauer, et al.Journal of Clinical Laboratory Analysis|January 4, 2001
Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitroU Elsässer-Beile, M Voss, R Schühle, et al.Der Urologe. Ausg. A|March 19, 2013
[UroLift®: an operative non-ablative procedure for treatment of benign prostatic syndrome]R Berges, K D Sievert, C Gratzke, et al.The Journal of Urology|October 1, 1991
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patientsC G Stief, U Wetterauer, F H Schaebsdau, et al.Anticancer Research|August 6, 2000
Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancerA Katzenwadel, H Schleer, D Gierschner, et al.Cancer|March 17, 2001
Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat modelU Elsässer-Beile, T Ruhnau, N Freudenberg, et al.International Journal of Andrology|September 28, 1998
Transurethral resection of cystic and non-cystic ejaculatory duct obstructionsG Popken, U Wetterauer, W Schultze-Seemann, et al.Der Radiologe|February 1, 1983
[Sonography, urography and angiography in kidney carcinoma. A comparative study]W R Seemann, B Wimmer, W Rau, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2006
A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cellsP Wolf, D Gierschner, P Bühler, et al.European Urology|June 5, 1998
Anastomotic stricture after radical prostatectomy. Incidence, findings and treatmentG Popken, H Sommerkamp, W Schultze-Seemann, et al.Pageof 13